March 31, 2025 Marketing Team Press Releases Promising Data for Transdermal Curcumin in Sickle Cell Disease Read More March 31, 2025 Marketing Team Press Releases Vascarta Presents Breakthrough Sickle Cell Treatment at ASH Conference Read More March 31, 2025 Marketing Team Press Releases Patented transdermal drug candidate from Vascarta may offer a convenient & cost-effective way to treat sickle cell disease Read More January 13, 2025 Marketing Team Scientific Papers Published poster: “Mechanism-based Targeting of Sickle Cell Pathobiology and Pain with Novel Transdermal Curcumin” Read More January 13, 2025 Marketing Team Scientific Papers FDA CBER & Vascarta Research Plan – Mechanistic insights into blood storage lesions and the development of antioxidant countermeasures Read More January 13, 2025 Marketing Team Scientific Papers Novel Transdermal Curcumin Therapeutic Preserves Endothelial Barrier Function in a Rat Model of Sepsis. Read More January 13, 2025 Marketing Team Scientific Papers Novel transdermal curcumin therapeutic preserves endothelial barrier function in a high-dose LPS rat model; ARTIFICIAL CELLS, NANOMEDICINE, AND BIOTECHNOLOGY 2023, VOL. 51, NO. 1, 33–40) Read More January 13, 2025 Marketing Team Scientific Papers Joel Friedman: Harnessing An Ancient Remedy Einstein Magazine Winter-Spring 2023 Read More Previous page 1 2 3
